The global Orthobiologics Market is projected to be valued at USD 5,762.7 million in 2025, reaching USD 8,287.3 million by 2035, with a compound annual growth rate (CAGR) of 3.7% during the forecast ...

Selecting the right tissue bank is essential for ensuring the safety and effectiveness of allograft implants. Learn how to ...

Mesoblast shares jumped after the biotechnology group reported "continued momentum" with the US Food and Drug Administration ...

Among the 7MM, Japan accounts for the second highest total aplastic anemia drugs market. The Aplastic Anemia Treatment Market ...

Join Drs Tania Jain and Rachel Salit as they explore evolving definitions of remission, relapse monitoring, and ...

Korean regenerative medicine company CGBio, affiliated with Daewoong Pharmaceutical, announced Monday the establishment of Sol Cent Bio Co. Ltd., a joint ventur ...

Have undergone any procedure within 12 months of the study enrollment using biological treatment for any condition such as bone marrow aspirate concentrate, PRP, bone marrow-derived MSCs, ...

Bhubaneswar: Doctors of Kalinga Institute of Medical Sciences (KIMS) recently successfully performed a rare allogeneic bone marrow transplant on a 17-year-old female patient diagnosed with ...

Bhubaneswar, June 4 (UNI) In a major achievement, doctors at the Kalinga Institute of Medical Sciences (KIMS) have successfully performed a rare allogeneic bone marrow transplant on a 17-year-old ...

With improvements in allogeneic bone marrow transplantation ... Although a small fraction of patients may have graft failure or graft-versus-host disease, the outcomes in terms of residual ...